Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  'Thousand Oaks'  -  Page 66
Latest

Lloyd Properties donates 860 acres of Ventura hillsides to land trust

By   /  Friday, October 14th, 2016  /  Columns, Latest news, Real Estate  /  Comments Off on Lloyd Properties donates 860 acres of Ventura hillsides to land trust

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen spends big to defeat Proposition 61

By   /  Friday, October 14th, 2016  /  Central Coast Health Watch, Law, Top Stories, Top Story  /  Comments Off on Amgen spends big to defeat Proposition 61

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen sells Colorado facility to AstraZeneca for $64.5 million

By   /  Tuesday, October 11th, 2016  /  Central Coast Health Watch, Latest news, Real Estate  /  Comments Off on Amgen sells Colorado facility to AstraZeneca for $64.5 million

Thousand Oaks biotech giant Amgen continued its Colorado exit plans recently as it sold a Longmont, Colo., facility to London-based pharmaceutical and biotech company AstraZeneca for $64.5 million. Amgen built the 692,000-square-foot facility in the 1990s to make ingredients for its blockbuster anti-anemia drug Epogen. The site used large vats to produce lines of cell Read More →

Read More →
Latest

VC housing projects can’t compete for state funds

By   /  Friday, October 7th, 2016  /  East Ventura County, Real Estate, Top Stories, Top Story, West Ventura County  /  Comments Off on VC housing projects can’t compete for state funds

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Thousand Oaks apartment complex sells for $67 million

By   /  Thursday, October 6th, 2016  /  Latest news, Real Estate  /  Comments Off on Thousand Oaks apartment complex sells for $67 million

A 191-unit multifamily community at 491 W. Gainsborough Road in Thousand Oaks sold for $67 million. Pacific Urban Residential bought the property from IMT Capital LLC, according to Greg Harris of Marcus & Millichap who coordinated the deal. “The acquisition provided the buyer with the opportunity to enter a highly coveted market supported by the Read More →

Read More →
Latest

Amgen partners with Swedish company to develop drugs

By   /  Tuesday, October 4th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen partners with Swedish company to develop drugs

Thousand Oaks-based Amgen will pay a Swedish company up to $410 million to help it develop oncology and neuroscience drugs. The companies announced the partnership Oct. 4 and said Nuevolution will use its Chemetics drug discovery platform to discover drugs for Amgen. Nuevolution may receive licensing payments along with development, commercial and milestone payments. It Read More →

Read More →
Latest

Amgen leukemia drug cures 39 percent of treated patients, study finds

By   /  Tuesday, October 4th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen leukemia drug cures 39 percent of treated patients, study finds

Amgen’s new leukemia drug cured 39 percent of pediatric patients who received treatment, the Thousand Oaks company said Oct. 3 after publishing results of a new study in the Journal of Clinical Oncology. Blincyto, which treats a rare form of the disease known as precursor B-cell acute lymphoblastic leukemia, sent 27 patients out of 70 Read More →

Read More →